QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
||
For the quarterly period ended |
||
OR | ||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||
For the transition period |
from ________ to ________ |
|
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
||
(Address of Principal Executive Offices) |
(Zip Code) |
||
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
||
Nasdaq Texas, LLC |
||||
☒ |
Accelerated filer |
☐ |
|
Non-accelerated filer |
☐ |
Smaller reporting company |
|
Emerging growth company |
Class |
Outstanding at April 16, 2026 |
||
Common Stock, $0.01 par value per share |
shares |
||
TABLE OF CONTENTS |
|||
PART I |
|||
Item 1. |
|||
Item 2. |
|||
Item 3. |
|||
Item 4. |
|||
PART II |
|||
Item 1. |
|||
Item 1A. |
|||
Item 2. |
|||
Item 5. |
|||
Item 6. |
|||
March 31, 2026 |
December 31, 2025 |
||
(unaudited) |
|||
Assets |
|||
Current assets: |
|||
Cash and cash equivalents |
$ |
$ |
|
Restricted cash and cash equivalents |
|||
Default funds and margin deposits (including restricted cash and cash equivalents of
$
|
|||
Financial investments |
|||
Receivables, net |
|||
Other current assets |
|||
Total current assets |
|||
Property and equipment, net |
|||
Goodwill |
|||
Intangible assets, net |
|||
Operating lease assets |
|||
Other non-current assets |
|||
Total assets |
$ |
$ |
|
Liabilities |
|||
Current liabilities: |
|||
Accounts payable and accrued expenses |
$ |
$ |
|
Accrued personnel costs |
|||
Deferred revenue |
|||
Other current liabilities |
|||
Default funds and margin deposits |
|||
Short-term debt |
|||
Total current liabilities |
|||
Long-term debt |
|||
Deferred tax liabilities, net |
|||
Operating lease liabilities |
|||
Other non-current liabilities |
|||
Total liabilities |
|||
Commitments and contingencies |
|||
Equity |
|||
Nasdaq stockholders’ equity: |
|||
Common stock, $
outstanding:
|
|||
Additional paid-in capital |
|||
Common stock in treasury, at cost:
shares at December 31, 2025
|
( |
( |
|
Accumulated other comprehensive loss |
( |
( |
|
Retained earnings |
|||
Total Nasdaq stockholders’ equity |
|||
Noncontrolling interests |
|||
Total equity |
|||
Total liabilities and equity |
$ |
$ |
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Revenues: |
|||
Capital Access Platforms |
$ |
$ |
|
Financial Technology |
|||
Market Services |
|||
Other revenues |
|||
Total revenues |
|||
Transaction-based expenses: |
|||
Transaction rebates |
( |
( |
|
Brokerage, clearance and exchange fees |
( |
( |
|
Revenues less transaction-based expenses |
|||
Operating expenses: |
|||
Compensation and benefits |
|||
Professional and contract services |
|||
Technology and communication infrastructure |
|||
Occupancy |
|||
General, administrative and other |
|||
Marketing and advertising |
|||
Depreciation and amortization |
|||
Regulatory |
|||
Merger and strategic initiatives |
|||
Restructuring charges |
|||
Total operating expenses |
|||
Operating income |
|||
Interest income |
|||
Interest expense |
( |
( |
|
Net gain on divestitures |
|||
Other losses |
( |
( |
|
Net income from unconsolidated investees |
|||
Income before income taxes |
|||
Income tax provision |
|||
Net income |
$ |
$ |
|
Per share information: |
|||
Basic earnings per share |
$ |
$ |
|
Diluted earnings per share |
$ |
$ |
|
Cash dividends declared per common share |
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Net income |
$ |
$ |
|
Other comprehensive income (loss): |
|||
Foreign currency translation gains (losses) |
( |
||
Income tax benefit (expense)(1)
|
( |
||
Foreign currency translation, net |
( |
||
Unrealized gain (loss) on derivatives instruments, net |
( |
||
Total other comprehensive income (loss), net of tax |
( |
||
Comprehensive income |
$ |
$ |
|
Three Months Ended March 31, |
|||||||
2026 |
2025 |
||||||
Shares |
$ |
Shares |
$ |
||||
Common stock |
|||||||
Additional paid-in capital |
|||||||
Beginning balance |
|||||||
Share repurchase program |
( |
( |
( |
( |
|||
Share-based compensation |
|||||||
Issuance of stock under employee stock plans |
— |
||||||
Ending balance |
|||||||
Common stock in treasury, at cost |
|||||||
Beginning balance |
( |
( |
|||||
Employee shares withheld |
( |
( |
( |
( |
|||
Ending balance |
( |
( |
|||||
Accumulated other comprehensive loss |
|||||||
Beginning balance |
( |
( |
|||||
Other comprehensive income (loss) |
( |
||||||
Ending balance |
( |
( |
|||||
Retained earnings |
|||||||
Beginning balance |
|||||||
Net income |
|||||||
Cash dividends declared and paid |
( |
( |
|||||
Ending balance |
|||||||
Total Nasdaq stockholders’ equity |
|||||||
Noncontrolling interests |
|||||||
Beginning balance |
|||||||
Net activity related to noncontrolling interests |
— |
— |
|||||
Ending balance |
|||||||
Total Equity |
$ |
$ |
|||||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Cash flows from operating activities: |
|||
Net income |
$ |
$ |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation and amortization |
|||
Share-based compensation |
|||
Deferred income tax expense |
|||
Net gain on divestitures |
( |
||
Net income from unconsolidated investees |
( |
( |
|
Other reconciling items included in net income |
( |
||
Net change in operating assets and liabilities, excluding the effects of divestitures: |
|||
Receivables, net |
( |
||
Other assets |
|||
Accounts payable and accrued expenses |
( |
( |
|
Section 31 fees payable to SEC |
( |
||
Accrued personnel costs |
( |
( |
|
Deferred revenue |
|||
Other liabilities |
( |
( |
|
Net cash provided by operating activities |
|||
Cash flows from investing activities: |
|||
Purchases of securities |
( |
( |
|
Proceeds from sales and redemptions of securities |
|||
Purchases of property and equipment |
( |
( |
|
Investments related to default funds and margin deposits, net(1)
|
( |
||
Other investing activities |
( |
( |
|
Net cash provided by (used in) investing activities |
( |
||
Cash flows from financing activities: |
|||
Repayments of debt and credit commitment |
( |
||
Repurchases of common stock |
( |
( |
|
Dividends paid |
( |
( |
|
Proceeds from issuance of stock under employee stock plans |
|||
Payments related to employee shares withheld for taxes |
( |
( |
|
Default funds and margin deposits |
( |
( |
|
Other financing activities |
|||
Net cash used in financing activities |
( |
( |
|
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents |
( |
||
Net decrease in cash and cash equivalents and restricted cash and cash equivalents |
( |
( |
|
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period
|
|||
Cash and cash equivalents, restricted cash and cash equivalents at end of period |
$ |
$ |
|
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents |
|||
Cash and cash equivalents |
$ |
$ |
|
Restricted cash and cash equivalents |
|||
Restricted cash and cash equivalents (default funds and margin deposits) |
|||
Total |
$ |
$ |
|
Supplemental Disclosure - Cash Flow Information |
|||
Cash paid for: |
|||
Interest paid |
$ |
$ |
|
Income taxes paid, net of refunds |
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Capital Access Platforms |
|||
Data & Listing Services |
$ |
$ |
|
Index |
|||
Workflow & Insights |
|||
Financial Technology |
|||
Financial Crime Management
Technology
|
|||
Regulatory Technology |
|||
Capital Markets Technology |
|||
Market Services, net |
|||
Other revenues |
|||
Revenues less transaction-based
expenses
|
$ |
$ |
|
Financial
Crime
Management
Technology
|
Regulatory
Technology
|
Capital
Markets
Technology
|
Workflow
&
Insights
|
Total |
|||||
(in millions) |
|||||||||
Remainder
of 2026
|
$ |
$ |
$ |
$ |
$ |
||||
2027 |
|||||||||
2028 |
|||||||||
2029 |
|||||||||
2030 |
|||||||||
2031+ |
|||||||||
Total |
$ |
$ |
$ |
$ |
$ |
||||
(in millions) |
|
Capital Access Platforms |
|
Balance at December 31, 2025 |
$ |
Foreign currency translation adjustments |
( |
Balance at March 31, 2026 |
$ |
Financial Technology |
|
Balance at December 31, 2025 |
$ |
Foreign currency translation adjustments |
( |
Balance at March 31, 2026 |
$ |
Market Services |
|
Balance at December 31, 2025 |
$ |
Foreign currency translation adjustments |
( |
Balance at March 31, 2026 |
$ |
Total |
|
Balance at December 31, 2025 |
$ |
Foreign currency translation adjustments |
( |
Balance at March 31, 2026 |
$ |
March 31,
2026
|
December 31,
2025
|
||
Finite-Lived Intangible Assets |
(in millions) |
||
Gross Amount: |
|||
Technology |
$ |
$ |
|
Customer relationships |
|||
Trade names and other |
|||
Foreign currency translation
adjustment
|
( |
( |
|
Total gross amount |
$ |
$ |
|
Accumulated Amortization: |
|||
Technology |
$( |
$( |
|
Customer relationships |
( |
( |
|
Trade names and other |
( |
( |
|
Foreign currency translation
adjustment
|
|||
Total accumulated amortization |
$( |
$( |
|
Net Amount: |
|||
Technology |
$ |
$ |
|
Customer relationships |
|||
Trade names and other |
|||
Foreign currency translation
adjustment
|
( |
( |
|
Total finite-lived intangible assets |
$ |
$ |
|
Indefinite-Lived Intangible Assets |
|||
Exchange and clearing registrations |
$ |
$ |
|
Trade names |
|||
Licenses |
|||
Foreign currency translation
adjustment
|
( |
( |
|
Total indefinite-lived intangible
assets
|
$ |
$ |
|
Total intangible assets, net |
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Amortization expense |
$ |
$ |
|
(in millions) |
|
Remainder of 2026 |
$ |
2027 |
|
2028 |
|
2029 |
|
2030 |
|
2031+ |
|
Total |
$ |
March 31, 2026 |
December 31, 2025 |
||
(in millions) |
|||
Financial investments |
$ |
$ |
|
Equity method investments |
|||
Equity securities |
|||
Balance at
December
31, 2025
|
Additions |
Revenue
Recognized
|
Foreign
Currency
Translation
|
Balance at
March
31, 2026
|
|
Capital Access Platforms: |
(in millions) |
||||
Initial Listings |
$ |
$ |
$( |
$ |
$ |
Annual
Listings
|
( |
( |
|||
Workflow &
Insights
|
( |
( |
|||
Other |
( |
||||
Financial Technology: |
|||||
Financial
Crime
Management
Technology
|
( |
||||
Regulatory
Technology
|
( |
||||
Capital
Markets
Technology
|
( |
( |
|||
Total |
$ |
$ |
$( |
$( |
$ |
Fiscal year
ended:
|
2026 |
2027 |
2028 |
2029 |
2030 |
2031+ |
Total |
Capital Access Platforms: |
(in millions) |
||||||
Initial
Listings
|
$ |
$ |
$ |
$ |
$ |
$ |
$ |
Annual
Listings
|
|||||||
Workflow &
Insights
|
|||||||
Other |
|||||||
Financial Technology: |
|||||||
Financial
Crime
Management
Technology
|
|||||||
Regulatory
Technology
|
|||||||
Capital
Markets
Technology
|
|||||||
Total |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
December 31,
2025
|
Payments, Foreign
Currency
Translation
and Accretion
|
March 31,
2026
|
|||
Short-term debt: |
(in millions) |
||||
2026 Notes |
$ |
$ |
$ |
||
Total short-term debt |
$ |
$ |
$ |
||
Long-term debt - senior unsecured notes: | |||||
2028 Notes |
|||||
2029 Notes |
( |
||||
2030 Notes |
( |
||||
2031 Notes |
|||||
2032 Notes |
( |
||||
2033 Notes |
( |
||||
2034 Notes |
|||||
2040 Notes |
|||||
2050 Notes |
|||||
2052 Notes |
|||||
2053 Notes |
|||||
2063 Notes |
|||||
2022 Revolving
Credit Facility
|
( |
( |
|||
Total long-term debt |
$ |
$( |
$ |
||
Total debt
obligations
|
$ |
$( |
$ |
||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Savings Plan expense |
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Retirement Plans expense |
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
|
(in millions) |
|||
Share-based compensation
expense before income taxes
|
$ |
$ |
|
Restricted Stock |
|||
Number of Awards |
Weighted-Average
Grant Date Fair
Value
|
||
Unvested at December 31,
2025
|
$ |
||
Granted |
|||
Vested |
( |
||
Forfeited |
( |
||
Unvested at March 31,
2026
|
$ |
||
PSUs |
||||
Number of
Awards
|
Weighted-
Average Grant
Date Fair Value
|
|||
Unvested at December 31,
2025
|
$ |
|||
Granted |
||||
Vested |
( |
|||
Forfeited |
( |
|||
Unvested at March 31, 2026 |
$ |
|||
Number of
Stock
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term (in
years)
|
Aggregate
Intrinsic
Value (in
millions)
|
|
Outstanding at
December 31, 2025
|
$ |
|||
Exercised |
( |
|||
Outstanding at
March 31, 2026
|
$ |
$ |
||
Exercisable at
March 31, 2026
|
$ |
$ |
Three Months Ended
March 31, 2026
|
|
Number of shares of common stock
repurchased
|
|
Average price paid per share |
$ |
Total purchase price (in millions)
|
$ |
Declaration Date |
Dividend Per
Common
Share
|
Record Date |
Total
Amount
Paid
|
Payment
Date
|
||||
(in millions) |
||||||||
January 28,
2026
|
$ |
March 16,
2026
|
$ |
March 30,
2026
|
||||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Numerator: |
(in millions, except share and per
share amounts)
|
||
Net income |
$ |
$ |
|
Denominator: |
|||
Weighted-average common
shares outstanding for basic
earnings per share
|
|||
Weighted-average effect of
dilutive securities -
Employee equity awards
|
|||
Weighted-average common
shares outstanding for
diluted earnings per share
|
|||
Basic and diluted earnings per share: | |||
Basic earnings per share |
$ |
$ |
|
Diluted earnings per share |
$ |
$ |
|
March 31, 2026 |
|||||||
Total |
Level 1 |
Level 2 |
Level 3 |
||||
(in millions) |
|||||||
European
government debt
securities
|
$ |
$ |
$ |
$ |
|||
State-owned
enterprises and
municipal
securities
|
|||||||
Total financial
investments
|
$ |
$ |
$ |
$ |
|||
Equity securities |
|||||||
Total assets at fair
value
|
$ |
$ |
$ |
$ |
|||
December 31, 2025 |
|||||||
Total |
Level 1 |
Level 2 |
Level 3 |
||||
(in millions) |
|||||||
European
government debt
securities
|
$ |
$ |
$ |
$ |
|||
Total financial
investments
|
$ |
$ |
$ |
$ |
|||
Equity securities |
|||||||
Total assets at fair
value
|
$ |
$ |
$ |
$ |
|||
March 31, 2026 |
|||||
Cash
Contributions
|
Non-Cash
Contributions
|
Total
Contributions
|
|||
(in millions) |
|||||
Default fund
contributions
|
$ |
$ |
$ |
||
Margin deposits |
|||||
Total |
$ |
$ |
$ |
||
March 31, 2026 |
December 31, 2025 |
||
(in millions) |
|||
Demand deposits |
$ |
$ |
|
Central bank certificates |
|||
Restricted cash and cash
equivalents
|
$ |
$ |
|
European government debt
securities
|
|||
Reverse repurchase
agreements
|
|||
Multilateral development
bank debt securities
|
|||
Investments |
$ |
$ |
|
Total |
$ |
$ |
|
March 31, 2026 |
|
(in millions) |
|
Commodity forwards |
$ |
Fixed-income swaps and forwards |
|
Stock options and forwards |
|
Index options and forwards |
|
Total |
$ |
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Commodity futures and forwards |
|||
Fixed-income swaps, futures and
forwards
|
|||
Stock options, futures and
forwards
|
|||
Index options, futures and
forwards
|
|||
Total |
|||
Balance Sheet
Classification
|
March 31, 2026 |
December 31, 2025 |
||||
Assets: |
(in millions) |
|||||
Operating
lease
assets
|
Operating
lease assets
|
$ |
$ |
|||
Liabilities: |
||||||
Current
lease
liabilities
|
Other current
liabilities
|
$ |
$ |
|||
Non-
current
lease
liabilities
|
Operating
lease
liabilities
|
|||||
Total lease
liabilities
|
$ |
$ |
||||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Operating lease cost |
$ |
$ |
|
Variable lease cost |
|||
Sublease income |
( |
( |
|
Total lease cost |
$ |
$ |
|
March 31, 2026 |
||
(in millions) |
||
Remainder of 2026 |
$ |
|
2027 |
||
2028 |
||
2029 |
||
2030 |
||
2031+ |
||
Total lease payments |
$ |
|
Less: interest |
( |
|
Present value of lease liabilities |
$ |
March 31, 2026 |
||
Weighted-average remaining lease term
(in years)
|
||
Weighted-average discount rate |
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Cash paid for amounts included in
the measurement of operating
lease liabilities
|
$ |
$ |
|
Lease assets obtained in exchange
for operating lease liabilities
|
$ |
$ |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Income tax provision |
$ |
$ |
|
Effective tax rate |
|||
Capital
Access
Platforms
|
Financial
Technology
|
Market
Services
|
Corporate |
Total |
|
March 31, 2026 |
(in millions) |
||||
Total
revenues
|
$ |
$ |
$ |
$ |
$ |
Transaction-
based
expenses
|
— |
— |
( |
— |
( |
Revenues less
transaction-
based
expenses
|
|||||
Directly
consumed
expenses
|
— |
||||
Other
expenses
|
|||||
Operating
income
|
$ |
$ |
$ |
$( |
$ |
Depreciation
and
amortization
|
|||||
Purchases of
property and
equipment
|
— |
||||
Capital
Access
Platforms
|
Financial
Technology
|
Market
Services
|
Corporate |
Total |
|
March 31, 2025 |
|||||
Total
revenues
|
$ |
$ |
$ |
$ |
$ |
Transaction-
based
expenses
|
— |
— |
( |
— |
( |
Revenues less
transaction-
based
expenses
|
|||||
Directly
consumed
expenses
|
— |
||||
Other
expenses
|
|||||
Operating
income
|
$ |
$ |
$ |
$( |
$ |
Depreciation
and
amortization
|
|||||
Purchases of
property and
equipment
|
— |
||||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Revenues: |
(in millions) |
||
Divestitures of businesses |
$ |
$ |
|
Expenses: |
|||
Amortization expense of
acquired intangible assets
|
|||
Merger and strategic initiatives
expense
|
|||
Restructuring charges |
|||
Legal and regulatory matters |
|||
Gain on extinguishment of debt |
( |
||
Expenses - divestitures |
|||
Other |
|||
Total expenses |
$ |
$ |
|
Operating loss |
$( |
$( |
|
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
United States |
$ |
$ |
|
All other countries |
|||
Total |
$ |
$ |
|
(in millions) |
March 31, 2026 |
December 31, 2025 |
|
United States |
$ |
$ |
|
All other countries |
|||
Total |
$ |
$ |
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions) |
|||
Consulting services |
$ |
$ |
|
Employee-related costs |
|||
Other |
|||
Total restructuring charges |
$ |
$ |
|
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions, except per share
amounts)
|
|||||
Revenues less
transaction-based
expenses
|
$1,407 |
$1,237 |
13.8% |
||
Operating expenses |
750 |
690 |
8.8% |
||
Operating income |
$657 |
$547 |
20.1% |
||
Net income |
$519 |
$395 |
31.4% |
||
Diluted earnings per
share
|
$0.91 |
$0.68 |
33.3% |
||
Cash dividends
declared per common
share
|
$0.27 |
$0.24 |
12.5% |
||

▪ |
Capital Access Platforms |
|
◦ |
Proprietary market data subscriptions and
annual listing fees within our Data & Listing
Services business
|
|
◦ |
Index data subscriptions and guaranteed
minimum on futures contracts within our Index
business
|
|
◦ |
Subscription contracts under our Workflow &
Insights business
|
|
▪ |
Financial Technology |
|
◦ |
Subscription contracts excluding non-recurring
professional services.
|
|
▪ |
Other includes ARR related to our Solovis business
divested in October 2025.
|
|

Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Capital Access
Platforms
|
$565 |
$508 |
11.4% |
||
Financial Technology |
517 |
432 |
19.7% |
||
Market Services |
1,047 |
1,140 |
(8.1)% |
||
Other revenues |
8 |
16 |
(50.6)% |
||
Total revenues |
$2,137 |
$2,096 |
2.0% |
||
Transaction rebates |
(724) |
(585) |
23.9% |
||
Brokerage, clearance
and exchange fees
|
(6) |
(274) |
(97.9)% |
||
Total revenues less
transaction-based
expenses
|
$1,407 |
$1,237 |
13.8% |
||

Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Data & Listing
Services
|
$214 |
$192 |
11.4% |
||
Index |
220 |
193 |
14.4% |
||
Workflow & Insights |
131 |
123 |
6.7% |
||
Total Capital Access
Platforms
|
$565 |
$508 |
11.4% |
||
As of March 31, |
||||
2026 |
2025 |
|||
ARR (in millions) |
$1,366 |
$1,252 |
||
Three Months Ended March 31, |
|||
IPOs |
2026 |
2025 |
|
The Nasdaq Stock Market |
63 |
63 |
|
Operating company |
15 |
45 |
|
SPACs |
48 |
18 |
|
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic
|
— |
4 |
|
Total new listings |
|||
The Nasdaq Stock Market |
176 |
170 |
|
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic
|
5 |
9 |
|
As of December 31 |
|||
Number of listed companies |
2026 |
2025 |
|
The Nasdaq Stock Market |
4,570 |
4,139 |
|
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic
|
1,107 |
1,160 |
|
ARR (in millions) |
$777 |
$701 |
|
As of or
Three Months Ended March 31,
|
||||
2026 |
2025 |
|||
Number of licensed ETPs |
470 |
418 |
||
TTM change in period end ETP AUM tracking Nasdaq
indices (in billions)
| ||||
Beginning balance |
$622 |
$519 |
||
Net appreciation |
135 |
17 |
||
Net inflows |
79 |
86 |
||
Ending balance |
$836 |
$622 |
||
Quarterly average ETP AUM
tracking Nasdaq indices (in
billions)
|
$877 |
$662 |
||
ARR (in millions) |
$85 |
$79 |
||
As of or
Three Months Ended March 31,
|
|||
2026 |
2025 |
||
(in millions) |
|||
ARR |
$504 |
$472 |
|
Quarterly annualized SaaS
revenues
|
432 |
401 |
|
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Financial Crime
Management Technology
|
$93 |
$77 |
21.0% |
||
Regulatory Technology |
118 |
101 |
16.4% |
||
Capital Markets
Technology
|
306 |
254 |
20.6% |
||
Total Financial
Technology
|
$517 |
$432 |
19.7% |
||
As of or
Three Months Ended March 31,
|
||||
2026 |
2025 |
|||
(in millions) |
||||
ARR and Quarterly annualized
SaaS revenues
|
$344 |
$295 |
||
As of or
Three Months Ended March 31,
|
||||
2026 |
2025 |
|||
(in millions) |
||||
ARR |
$419 |
$362 |
||
Quarterly annualized SaaS
revenues
|
252 |
197 |
||
As of or
Three Months Ended March 31,
|
|||
2026 |
2025 |
||
(in millions) |
|||
ARR |
$1,059 |
$893 |
|
Quarterly annualized SaaS
revenues
|
174 |
139 |
|
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Market Services |
$1,047 |
$1,140 |
(8.1)% |
||
Transaction-based expenses: |
|||||
Transaction rebates |
(724) |
(585) |
23.9% |
||
Brokerage,
clearance and
exchange fees
|
(6) |
(274) |
(97.9)% |
||
Total Market Services,
net
|
$317 |
$281 |
12.8% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
U.S. Equity Derivative
Trading
|
$120 |
$108 |
10.7% |
||
Cash Equity Trading |
138 |
121 |
14.8% |
||
U.S. Tape plans |
33 |
33 |
1.5% |
||
Other |
26 |
19 |
30.7% |
||
Total Market Services,
net
|
$317 |
$281 |
12.8% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
U.S. Equity Derivative
Trading Revenues
|
$432 |
$409 |
7.3% |
||
Section 31 fees |
— |
32 |
(100.0)% |
||
Transaction-based expenses: |
|||||
Transaction rebates |
(312) |
(299) |
6.4% |
||
Section 31 fees |
— |
(32) |
(100.0)% |
||
Brokerage and
clearance fees
|
— |
(2) |
(79.5)% |
||
U.S. Equity Derivative
Trading Revenues, net
|
$120 |
$108 |
10.7% |
||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Total industry average daily
volume (in millions)
|
62.6 |
53.6 |
|
Nasdaq PHLX matched market
share
|
12.5% |
9.1% |
|
The Nasdaq Options Market
matched market share
|
2.6% |
5.1% |
|
Nasdaq Texas Options matched
market share
|
1.3% |
1.7% |
|
Nasdaq ISE Options matched
market share
|
6.0% |
6.8% |
|
Nasdaq GEMX Options matched
market share
|
3.4% |
3.6% |
|
Nasdaq MRX Options matched
market share
|
4.3% |
2.8% |
|
Total matched market share
executed on Nasdaq’s exchanges
|
30.1% |
29.1% |
|
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Cash Equity Trading
Revenues
|
$548 |
$407 |
34.5% |
||
Section 31 fees |
— |
234 |
(100.0)% |
||
Transaction-based
expenses:
|
|||||
Transaction rebates |
(404) |
(280) |
44.4% |
||
Section 31 fees |
— |
(234) |
(100.0)% |
||
Brokerage and
clearance fees
|
(6) |
(6) |
(20.3)% |
||
Cash equity trading
revenues, net
|
$138 |
$121 |
14.8% |
||
Three Months Ended March 31, |
|||
Total U.S.-listed securities |
2026 |
2025 |
|
Total industry average daily share
volume (in billions)
|
20.0 |
15.7 |
|
Matched share volume (in billions) |
183.7 |
137.6 |
|
The Nasdaq Stock Market matched
market share
|
14.7% |
14.2% |
|
Nasdaq Texas matched market share |
0.3% |
0.3% |
|
Nasdaq PSX matched market share |
0.1% |
0.1% |
|
Total matched market share executed
on Nasdaq’s exchanges
|
15.1% |
14.6% |
|
Market share reported to the FINRA/
Nasdaq Trade Reporting Facility
|
45.6% |
48.1% |
|
Total market share |
60.7% |
62.7% |
|
Nasdaq Nordic and Nasdaq Baltic securities | |||
Average daily number of equity trades
executed on Nasdaq’s exchanges
|
797,886 |
789,103 |
|
Total average daily value of shares
traded (in billions)
|
$6.8 |
$5.4 |
|
Total market share executed on
Nasdaq’s exchanges
|
74.3% |
70.5% |
|
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
U.S. Tape plans |
$33 |
$33 |
1.5% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Other |
$26 |
$19 |
30.7% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Compensation and
benefits
|
$356 |
$329 |
8.4% |
||
Professional and
contract services
|
39 |
36 |
8.5% |
||
Technology and
communication
infrastructure
|
84 |
77 |
8.0% |
||
Occupancy |
33 |
28 |
15.8% |
||
General, administrative
and other
|
29 |
6 |
458.3% |
||
Marketing and
advertising
|
20 |
14 |
42.2% |
||
Depreciation and
amortization
|
165 |
156 |
6.0% |
||
Regulatory |
9 |
15 |
(35.7)% |
||
Merger and strategic
initiatives
|
4 |
24 |
(84.7)% |
||
Restructuring charges |
11 |
5 |
103.4% |
||
Total operating
expenses
|
$750 |
$690 |
8.8% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Interest income |
$6 |
$11 |
(48.5)% |
||
Interest expense |
(87) |
(96) |
(10.1)% |
||
Net interest expense |
(81) |
(85) |
(5.1)% |
||
Net gain on
divestitures
|
89 |
— |
100.0% |
||
Other losses |
(14) |
(1) |
NM |
||
Net income from
unconsolidated
investees
|
26 |
27 |
(3.2)% |
||
Total non-operating
income (expense)
|
$20 |
$(59) |
(134.2)% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
(in millions) |
|||||
Interest expense on debt |
$84 |
$92 |
(10.0)% |
||
Accretion of debt
issuance costs and debt
discount
|
2 |
3 |
(13.8)% |
||
Other fees |
1 |
1 |
(10.0)% |
||
Interest expense |
$87 |
$96 |
(10.1)% |
||
Three Months Ended March 31, |
Percentage
Change
|
||||
2026 |
2025 |
||||
($ in millions) |
|||||
Income tax provision |
$158 |
$93 |
69.6% |
||
Effective tax rate |
23.4% |
19.1% |
|||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
(in millions, except per share
amounts)
|
|||
U.S. GAAP net income |
$519 |
$395 |
|
Non-GAAP adjustments: |
|||
Amortization expense of acquired
intangible assets
|
121 |
122 |
|
Merger and strategic initiatives
expense
|
4 |
24 |
|
Restructuring charges |
11 |
5 |
|
Gain on extinguishment of debt |
— |
(19) |
|
Net gain on divestitures |
(89) |
— |
|
Net income from unconsolidated
investees
|
(26) |
(27) |
|
Legal and regulatory matters |
6 |
2 |
|
Other loss |
15 |
1 |
|
Total non-GAAP adjustments |
$42 |
$108 |
|
Total non-GAAP tax
adjustments
|
(12) |
(28) |
|
Other tax adjustments |
— |
(19) |
|
Total non-GAAP adjustments,
net of tax
|
$30 |
$61 |
|
Non-GAAP net income |
$549 |
$456 |
|
U.S. GAAP effective tax rate |
23.4% |
19.1% |
|
Total adjustments from non-
GAAP tax rate
|
0.3% |
4.4% |
|
Non-GAAP effective tax rate |
23.7% |
23.5% |
|
Weighted-average common shares
outstanding for diluted earnings
per share
|
571.7 |
580.0 |
|
U.S. GAAP diluted earnings per
share
|
$0.91 |
$0.68 |
|
Total adjustments from non-
GAAP net income
|
0.05 |
0.11 |
|
Non-GAAP diluted earnings per
share
|
$0.96 |
$0.79 |
|
March 31, 2026 |
December 31, 2025 |
|||
(in millions) |
||||
Working capital |
$(17) |
$42 |
||
Cash and cash equivalents |
515 |
604 |
||
Financial investments |
184 |
28 |
||
Three Months Ended March 31, |
|||
2026 |
2025 |
||
Net cash provided by (used in): |
(in millions) |
||
Operating activities |
$689 |
$663 |
|
Investing activities |
747 |
(258) |
|
Financing activities |
(4,184) |
(1,083) |
|
2026 |
2025 |
||
First quarter |
$0.27 |
$0.24 |

Euro |
Swedish
Krona
|
Canadian
Dollar
|
Other
Foreign
Currencies
|
U.S.
Dollar
|
|
(in millions, except currency rate) |
|||||
Three Months Ended March 31, 2026 | |||||
Average FX
rate to the
U.S. dollar
|
1.171 |
0.110 |
0.729 |
# |
N/A |
Percentage of
revenues less
transaction-
based
expenses
|
7.2% |
3.7% |
0.7% |
3.9% |
84.5% |
Percentage of
operating
income
|
9.2% |
(1.5)% |
(5.5)% |
(6.3)% |
104.1% |
Impact of a
10% adverse
currency
fluctuation on
revenues less
transaction-
based
expenses
|
$(10) |
$(5) |
$(1) |
$(5) |
$— |
Impact of a
10% adverse
currency
fluctuation on
operating
income
|
$(6) |
$(1) |
$(4) |
$(4) |
$— |
Net Assets |
Impact of a 10%
Adverse Currency
Fluctuation
|
|||
(in millions) |
||||
Swedish Krona |
$3,301 |
$(330) |
||
Norwegian Krone |
218 |
(22) |
||
Canadian Dollar |
140 |
(14) |
||
Australian Dollar |
89 |
(9) |
||
British Pound |
84 |
(8) |
||
Period |
Total Number
of Shares
Purchased
|
Average
Price Paid
Per Share
|
Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Plans or
Programs
|
Maximum
Dollar
Value of
Shares
that May
Yet Be
Purchased
Under the
Plans or
Programs
(in
millions)
|
||||
January 2026 |
||||||||
Share
repurchase
program
|
2,094,972 |
$90.78 |
2,094,972 |
$939 |
||||
Employee
transactions
|
— |
$— |
N/A |
N/A |
||||
February 2026 |
||||||||
Share
repurchase
program
|
3,914,850 |
$84.77 |
3,914,850 |
$2,910 |
||||
Employee
transactions
|
— |
$— |
N/A |
N/A |
||||
March 2026 |
||||||||
Share
repurchase
program
|
308,992 |
$83.02 |
308,992 |
$2,884 |
||||
Employee
transactions
|
— |
$— |
N/A |
N/A |
||||
Total Quarter Ended March 31, 2026 | ||||||||
Share
repurchase
program
|
6,318,814 |
$86.67 |
6,318,814 |
$2,884 |
||||
Employee
transactions
|
— |
$— |
N/A |
N/A |
||||
Exhibit Number |
||
101 |
The following materials from the Nasdaq,
Inc. Quarterly Report on Form 10-Q for the
quarter ended March 31, 2026, formatted in
iXBRL (Inline eXtensible Business
Reporting Language): (i) Condensed
Consolidated Balance Sheets as of March 31,
2026 and December 31, 2025; (ii)
Condensed Consolidated Statements of
Income for the three months ended March
31, 2026 and 2025; (iii) Condensed
Consolidated Statements of Comprehensive
Income for the three months ended March
31, 2026 and 2025; (iv) Condensed
Consolidated Statements of Changes in
Stockholders’ Equity for the three months
ended March 31, 2026 and 2025; (v)
Condensed Consolidated Statements of Cash
Flows for the three months ended March 31,
2026 and 2025; and (vi) notes to condensed
consolidated financial statements.
|
|
104 |
Cover Page Interactive Data File, formatted
in iXBRL and contained in Exhibit 101.
|
Nasdaq, Inc. |
||
(Registrant) |
||
By: |
/s/ Adena T. Friedman |
|
Name: |
Adena T. Friedman |
|
Title: |
Chief Executive Officer |
|
Date: |
April 24, 2026 |
|
By: |
/s/ Sarah Youngwood |
|
Name: |
Sarah Youngwood |
|
Title: |
Executive Vice President and
Chief Financial Officer
|
|
Date: |
April 24, 2026 |
|
| /s/ Adena T. Friedman | |||||||||||
| Name: | Adena T. Friedman | ||||||||||
| Title: | Chief Executive Officer | ||||||||||
/s/ Sarah Youngwood |
|||||||||||
| Name: | Sarah Youngwood |
||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| /s/ Adena T. Friedman | |||||||||||
| Name: | Adena T. Friedman | ||||||||||
| Title: | Chief Executive Officer | ||||||||||
| Date: | April 24, 2026 | ||||||||||
/s/ Sarah Youngwood |
|||||||||||
| Name: | Sarah Youngwood |
||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Date: | April 24, 2026 | ||||||||||